title: [Statement of the Deutsche Ophthalmologische Gesellschaft (German Ophthalmological Society), the Retinologische Gesellschaft (German Retina Society) and the Berufsverband der Augenärzte Deutschlands (German Professional Association of Ophthalmologists) on the therapy of choroidal neovascularization in myopia. State: March 2014].
authors.affiliation: St. Franziskus Hospital, Hohenzollernring 74, 48145, Münster, Deutschland, dapauleikhoff@muenster.de.
authors.forename: D
authors.initials: D
authors.lastname: Pauleikhoff
authors.forename: B
authors.initials: B
authors.lastname: Bertram
authors.forename: D
authors.initials: D
authors.lastname: Claessens
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D020256:Choroidal Neovascularization / Q000150:complications / Q000188:drug therapy*; D003131:Combined Modality Therapy / Q000592:standards; D005858:Germany; D006801:Humans; D009216:Myopia / Q000150:complications / Q000188:drug therapy*; D009885:Ophthalmology / Q000592:standards*; D010778:Photochemotherapy / Q000592:standards*; D017319:Photosensitizing Agents / Q000008:administration & dosage; D011166:Porphyrins / Q000008:administration & dosage*; D000077362:Verteporfin; D014786:Vision Disorders / Q000209:etiology / Q000517:prevention & control*
chemical_list: D020533:Angiogenesis Inhibitors; D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin